Lv4
415 积分 2022-12-30 加入
Skin mesenchymal niches maintain and protect AML-initiating stem cells
15小时前
已完结
Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option
15小时前
已完结
Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression
15小时前
已完结
PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion
22天前
已完结
Real-world outcomes of chimeric antigen receptor T-cell therapy with pembrolizumab as holding and/or bridging therapy in relapsed/refractory primary mediastinal large B-cell lymphoma
22天前
已完结
Safety and effectiveness of lisocabtagene maraleucel following PD-1 blockade in relapsed or refractory PMBCL
22天前
已完结
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
25天前
已完结
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
25天前
已完结
Anti-BCMA/GPRC5D CAR T cells in patients with relapsed or refractory multiple myeloma who have extraosseous extramedullary disease
1个月前
已完结
Low-incidence adverse events (AEs): An emerging challenge in chimeric antigen receptor T-cell (CAR-T) therapy
1个月前
已完结
皖公网安备34019202002308
